Verrica Pharmaceuticals (VRCA)

• Market cap: $75.2M
• 1 day: -4.58%
• 5 days: -10.2%
• 1 month: 107.33%
• 3 months: 66.74%
• 6 months: 17.51%
• Year to date: 12.66%
• 1 year: -1.37%
• 5 years: -91.97%
• 10 years: -95.47%
• Sector: Healthcare
• Industry: Biotechnology

About: Verrica Pharmaceuticals Inc is a dermatology therapeutics company engaged in the development and commercialization of novel treatments that provide a meaningful benefit for people living with skin diseases. Its product candidate, VP-102, is developed for the treatment of molluscum contagiosum, or molluscum, a contagious and pediatric viral skin disease, and common warts.

Employees: 71